![](http://elea-en.com.vnct3013.avnam.net/wp-content/uploads/Render-Heberprot.png)
Heberprot-P
Injectable intralesional treatment for patients with severe diabetic foot ulcers.
Therapeutic Area
Diabetology
Active Ingredient
FCE Human Recombinant
Line
Diabetes + Oncology
Pharmaceutical Form
75 mcg lyophilized power x 6 ampoules
![Descargar](http://elea-en.com.vnct3013.avnam.net/wp-content/themes/elea/img/arrow-blue.png)